CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CVRx (NASDAQ: CVRX), a commercial-stage medical device company, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team is scheduled to deliver a presentation on Wednesday, January 15, 2025, at 2:15 PM Pacific Time. Interested parties can access a live audio webcast of the presentation through the investor relations section of CVRx's website at ir.cvrx.com.
CVRx (NASDAQ: CVRX), un'azienda di dispositivi medici in fase commerciale, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. Il team di gestione dell'azienda è programmato per effettuare una presentazione mercoledì 15 gennaio 2025, alle 14:15 ora del Pacifico. I soggetti interessati possono accedere a una diretta web audio della presentazione attraverso la sezione delle relazioni con gli investitori del sito web di CVRx all'indirizzo ir.cvrx.com.
CVRx (NASDAQ: CVRX), una empresa de dispositivos médicos en etapa comercial, ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan Healthcare. El equipo de gestión de la empresa está programado para ofrecer una presentación el miércoles 15 de enero de 2025, a las 2:15 PM, hora del Pacífico. Las partes interesadas pueden acceder a una transmisión de audio en vivo de la presentación a través de la sección de relaciones con inversores del sitio web de CVRx en ir.cvrx.com.
CVRx (NASDAQ: CVRX), 상업 단계의 의료 기기 회사,는 제43회 J.P. Morgan Healthcare 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진은 2025년 1월 15일 수요일 오후 2시 15분 태평양 표준시에 발표를 진행할 예정입니다. 관심 있는 분들은 CVRx 웹사이트의 투자자 관계 섹션(ir.cvrx.com)을 통해 발표의 생중계 오디오를 접속할 수 있습니다.
CVRx (NASDAQ: CVRX), une entreprise de dispositifs médicaux en phase commerciale, a annoncé sa participation à la 43ème Conférence Annuelle J.P. Morgan Healthcare. L'équipe de direction de l'entreprise doit présenter le mercredi 15 janvier 2025, à 14h15, heure du Pacifique. Les parties intéressées peuvent accéder à un webinaire audio en direct de la présentation via la section des relations investisseurs du site Web de CVRx à l'adresse ir.cvrx.com.
CVRx (NASDAQ: CVRX), ein Unternehmen für medizinische Geräte in der kommerziellen Phase, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz bekannt gegeben. Das Management-Team des Unternehmens wird am Mittwoch, den 15. Januar 2025, um 14:15 Uhr pazifischer Zeit eine Präsentation halten. Interessierte Parteien können über den Bereich Investor Relations auf der Website von CVRx unter ir.cvrx.com auf eine Live-Audioübertragung der Präsentation zugreifen.
- None.
- None.
MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. The Company is scheduled to present at 2:15 PM Pacific Time the same day via webcast.
A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.cvrx.com.
About CVRx, Inc.
CVRx is focused on the development and commercialization of the Barostim™ System, the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. Baroreceptors activate the body's baroreflex, which in turn triggers an autonomic response to the heart. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S. It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area. To learn more about Barostim, visit www.cvrx.com.
Investor Contact:
Mark Klausner or Mike Vallie
ICR Healthcare
443-213-0501
ir@cvrx.com
Media Contact:
Laura O’Neill
Finn Partners
402-499-8203
laura.oneill@finnpartners.com
FAQ
When is CVRx presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch CVRx's J.P. Morgan Healthcare Conference presentation?
Which healthcare conference will CVRx be presenting at in January 2025?
Will CVRx's presentation at the J.P. Morgan Healthcare Conference be available online?
